| Ident. | Authors (with country if any) | Title |
|---|
| 000028 (2013) |
Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France] | Trial designs used to study neuroprotective therapy in Parkinson's disease |
| 000126 (2013) |
Marjolein A. Van Der Marck [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; George F. Borm [Pays-Bas] ; Sebastiaan Overeem [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Mark Guttman [Canada] | Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial |
| 000148 (2013) |
| A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease |
| 000149 (2013) |
D. William Molloy [Irlande (pays)] ; T. I. Standish [Canada] ; Q. Zhou [Canada] ; G. Guyatt [Canada] | A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial |
| 000294 (2012) |
Jordan J. Elm [États-Unis] | Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long‐Term Study–1 |
| 000323 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome |
| 000326 (2012) |
Jo Watson [Canada] ; Ellen Hodnett ; B. Anthony Armson ; Barbara Davies ; Judy Watt-Watson | A Randomized Controlled Trial of the Effect of Intrapartum Intravenous Fluid Management on Breastfed Newborn Weight Loss |
| 000494 (2010) |
Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis] | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
| 000497 (2010) |
Adrian W. Laxton [Canada] ; David F. Tang-Wai [Canada] ; Mary Pat Mcandrews [Canada] ; Dominik Zumsteg [Suisse] ; Richard Wennberg [Canada] ; Ron Keren [Canada] ; John Wherrett [Canada] ; Gary Naglie [Canada] ; Clement Hamani [Canada] ; Gwenn S. Smith [États-Unis] ; Andres M. Lozano [Canada] | A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease |
| 000570 (2010) |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease |
| 000657 (2010) |
Elisa I. Glover [Canada] ; Joan Martin [Canada] ; Amy Maher [Canada] ; Rebecca E. Thornhill [Canada] ; Gerald R. Moran [Canada] ; Mark A. Tarnopolsky [Canada] | A randomized trial of coenzyme Q10 in mitochondrial disorders |
| 000675 (2009) |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 000793 (2009) |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease |
| 000824 (2009) |
Peter J. Trainer [Royaume-Uni] ; Shereen Ezzat [Canada] ; Gwyn A. D Ouza [Royaume-Uni] ; Gary Layton [Royaume-Uni] ; Christian J. Strasburger [Allemagne] | A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long‐acting octreotide in patients with acromegaly |
| 000831 (2008) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada] | Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial |
| 000946 (2008) |
Juan Pablo Appendino [Canada] ; Teesta Soman [Canada] | Correspondence on “Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy” |
| 000958 (2008) |
Richard L. Page [États-Unis] ; Edward L. C. Pritchett [États-Unis] ; Stuart Connolly [Canada] ; William E. Wilkinson [États-Unis] | Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia: Results of a Randomized Trial and Insights on the Concordance of Symptoms and Recurrent Arrhythmias |
| 000965 (2008) |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) |
| 000A40 (2007) |
Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial |
| 000B46 (2006) |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
| 000B95 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
